 | • レポートコード：MRC2-11QY06940 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は顆粒球マクロファージコロニー刺激因子のグローバル市場について調査・分析したレポートです。種類別（CG-0070、ギムシルマブ、GSK-3196165、レンジルマブ、MGN-1601、その他）市場規模、用途別（固形腫瘍、リンパ腫、腎臓がん、肺疾患、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別顆粒球マクロファージコロニー刺激因子の競争状況、市場シェア ・世界の顆粒球マクロファージコロニー刺激因子市場：種類別市場規模 2015年-2020年（CG-0070、ギムシルマブ、GSK-3196165、レンジルマブ、MGN-1601、その他） ・世界の顆粒球マクロファージコロニー刺激因子市場：種類別市場規模予測 2021年-2026年（CG-0070、ギムシルマブ、GSK-3196165、レンジルマブ、MGN-1601、その他） ・世界の顆粒球マクロファージコロニー刺激因子市場：用途別市場規模 2015年-2020年（固形腫瘍、リンパ腫、腎臓がん、肺疾患、その他） ・世界の顆粒球マクロファージコロニー刺激因子市場：用途別市場規模予測 2021年-2026年（固形腫瘍、リンパ腫、腎臓がん、肺疾患、その他） ・北米の顆粒球マクロファージコロニー刺激因子市場分析：米国、カナダ ・ヨーロッパの顆粒球マクロファージコロニー刺激因子市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの顆粒球マクロファージコロニー刺激因子市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の顆粒球マクロファージコロニー刺激因子市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの顆粒球マクロファージコロニー刺激因子市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Aduro BioTech Inc、Amgen Inc、BriaCell Therapeutics Corp、Cold Genesys Inc、GlaxoSmithKline Plc、Humanigen Inc、Mologen AG、Morphotek Inc、Sillajen Biotherapeutics、Takeda Pharmaceutical Co Ltd ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Granulocyte Macrophage Colony Stimulating Factor Market
The global Granulocyte Macrophage Colony Stimulating Factor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Granulocyte Macrophage Colony Stimulating Factor Scope and Market Size
Granulocyte Macrophage Colony Stimulating Factor market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Granulocyte Macrophage Colony Stimulating Factor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Granulocyte Macrophage Colony Stimulating Factor market is segmented into
CG-0070
Gimsilumab
GSK-3196165
Lenzilumab
MGN-1601
Others
Segment by Application, the Granulocyte Macrophage Colony Stimulating Factor market is segmented into
Solid Tumor
Lymphoma
Kidney Cancer
Lung Disease
Others
Regional and Country-level Analysis
The Granulocyte Macrophage Colony Stimulating Factor market is analysed and market size information is provided by regions (countries).
The key regions covered in the Granulocyte Macrophage Colony Stimulating Factor market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Granulocyte Macrophage Colony Stimulating Factor Market Share Analysis
Granulocyte Macrophage Colony Stimulating Factor market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Granulocyte Macrophage Colony Stimulating Factor business, the date to enter into the Granulocyte Macrophage Colony Stimulating Factor market, Granulocyte Macrophage Colony Stimulating Factor product introduction, recent developments, etc.
The major vendors covered:
Aduro BioTech Inc
Amgen Inc
BriaCell Therapeutics Corp
Cold Genesys Inc
GlaxoSmithKline Plc
Humanigen Inc
Mologen AG
Morphotek Inc
Sillajen Biotherapeutics
Takeda Pharmaceutical Co Ltd
1 Study Coverage
1.1 Granulocyte Macrophage Colony Stimulating Factor Product Introduction
1.2 Market Segments
1.3 Key Granulocyte Macrophage Colony Stimulating Factor Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Size Growth Rate by Type
1.4.2 CG-0070
1.4.3 Gimsilumab
1.4.4 GSK-3196165
1.4.5 Lenzilumab
1.4.6 MGN-1601
1.4.7 Others
1.5 Market by Application
1.5.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Size Growth Rate by Application
1.5.2 Solid Tumor
1.5.3 Lymphoma
1.5.4 Kidney Cancer
1.5.5 Lung Disease
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Size, Estimates and Forecasts
2.1.1 Global Granulocyte Macrophage Colony Stimulating Factor Revenue 2015-2026
2.1.2 Global Granulocyte Macrophage Colony Stimulating Factor Sales 2015-2026
2.2 Global Granulocyte Macrophage Colony Stimulating Factor, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Granulocyte Macrophage Colony Stimulating Factor Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Granulocyte Macrophage Colony Stimulating Factor Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Granulocyte Macrophage Colony Stimulating Factor Competitor Landscape by Players
3.1 Granulocyte Macrophage Colony Stimulating Factor Sales by Manufacturers
3.1.1 Granulocyte Macrophage Colony Stimulating Factor Sales by Manufacturers (2015-2020)
3.1.2 Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Manufacturers (2015-2020)
3.2 Granulocyte Macrophage Colony Stimulating Factor Revenue by Manufacturers
3.2.1 Granulocyte Macrophage Colony Stimulating Factor Revenue by Manufacturers (2015-2020)
3.2.2 Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Granulocyte Macrophage Colony Stimulating Factor Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Granulocyte Macrophage Colony Stimulating Factor Revenue in 2019
3.2.5 Global Granulocyte Macrophage Colony Stimulating Factor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Granulocyte Macrophage Colony Stimulating Factor Price by Manufacturers
3.4 Granulocyte Macrophage Colony Stimulating Factor Manufacturing Base Distribution, Product Types
3.4.1 Granulocyte Macrophage Colony Stimulating Factor Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Granulocyte Macrophage Colony Stimulating Factor Product Type
3.4.3 Date of International Manufacturers Enter into Granulocyte Macrophage Colony Stimulating Factor Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Size by Type (2015-2020)
4.1.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2015-2020)
4.1.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Type (2015-2020)
4.1.3 Granulocyte Macrophage Colony Stimulating Factor Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Type (2021-2026)
4.2.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Type (2021-2026)
4.2.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast by Type (2021-2026)
4.2.3 Granulocyte Macrophage Colony Stimulating Factor Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Granulocyte Macrophage Colony Stimulating Factor Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Size by Application (2015-2020)
5.1.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2015-2020)
5.1.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Application (2015-2020)
5.1.3 Granulocyte Macrophage Colony Stimulating Factor Price by Application (2015-2020)
5.2 Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Application (2021-2026)
5.2.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Application (2021-2026)
5.2.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast by Application (2021-2026)
5.2.3 Global Granulocyte Macrophage Colony Stimulating Factor Price Forecast by Application (2021-2026)
6 North America
6.1 North America Granulocyte Macrophage Colony Stimulating Factor by Country
6.1.1 North America Granulocyte Macrophage Colony Stimulating Factor Sales by Country
6.1.2 North America Granulocyte Macrophage Colony Stimulating Factor Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Granulocyte Macrophage Colony Stimulating Factor Market Facts & Figures by Type
6.3 North America Granulocyte Macrophage Colony Stimulating Factor Market Facts & Figures by Application
7 Europe
7.1 Europe Granulocyte Macrophage Colony Stimulating Factor by Country
7.1.1 Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Country
7.1.2 Europe Granulocyte Macrophage Colony Stimulating Factor Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Granulocyte Macrophage Colony Stimulating Factor Market Facts & Figures by Type
7.3 Europe Granulocyte Macrophage Colony Stimulating Factor Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor by Region
8.1.1 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales by Region
8.1.2 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Market Facts & Figures by Type
8.3 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Market Facts & Figures by Application
9 Latin America
9.1 Latin America Granulocyte Macrophage Colony Stimulating Factor by Country
9.1.1 Latin America Granulocyte Macrophage Colony Stimulating Factor Sales by Country
9.1.2 Latin America Granulocyte Macrophage Colony Stimulating Factor Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Granulocyte Macrophage Colony Stimulating Factor Market Facts & Figures by Type
9.3 Central & South America Granulocyte Macrophage Colony Stimulating Factor Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor by Country
10.1.1 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Country
10.1.2 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Market Facts & Figures by Type
10.3 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Market Facts & Figures by Application
11 Company Profiles
11.1 Aduro BioTech Inc
11.1.1 Aduro BioTech Inc Corporation Information
11.1.2 Aduro BioTech Inc Description and Business Overview
11.1.3 Aduro BioTech Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Products Offered
11.1.5 Aduro BioTech Inc Related Developments
11.2 Amgen Inc
11.2.1 Amgen Inc Corporation Information
11.2.2 Amgen Inc Description and Business Overview
11.2.3 Amgen Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Products Offered
11.2.5 Amgen Inc Related Developments
11.3 BriaCell Therapeutics Corp
11.3.1 BriaCell Therapeutics Corp Corporation Information
11.3.2 BriaCell Therapeutics Corp Description and Business Overview
11.3.3 BriaCell Therapeutics Corp Sales, Revenue and Gross Margin (2015-2020)
11.3.4 BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Products Offered
11.3.5 BriaCell Therapeutics Corp Related Developments
11.4 Cold Genesys Inc
11.4.1 Cold Genesys Inc Corporation Information
11.4.2 Cold Genesys Inc Description and Business Overview
11.4.3 Cold Genesys Inc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Products Offered
11.4.5 Cold Genesys Inc Related Developments
11.5 GlaxoSmithKline Plc
11.5.1 GlaxoSmithKline Plc Corporation Information
11.5.2 GlaxoSmithKline Plc Description and Business Overview
11.5.3 GlaxoSmithKline Plc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Products Offered
11.5.5 GlaxoSmithKline Plc Related Developments
11.6 Humanigen Inc
11.6.1 Humanigen Inc Corporation Information
11.6.2 Humanigen Inc Description and Business Overview
11.6.3 Humanigen Inc Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Products Offered
11.6.5 Humanigen Inc Related Developments
11.7 Mologen AG
11.7.1 Mologen AG Corporation Information
11.7.2 Mologen AG Description and Business Overview
11.7.3 Mologen AG Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Mologen AG Granulocyte Macrophage Colony Stimulating Factor Products Offered
11.7.5 Mologen AG Related Developments
11.8 Morphotek Inc
11.8.1 Morphotek Inc Corporation Information
11.8.2 Morphotek Inc Description and Business Overview
11.8.3 Morphotek Inc Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Products Offered
11.8.5 Morphotek Inc Related Developments
11.9 Sillajen Biotherapeutics
11.9.1 Sillajen Biotherapeutics Corporation Information
11.9.2 Sillajen Biotherapeutics Description and Business Overview
11.9.3 Sillajen Biotherapeutics Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Products Offered
11.9.5 Sillajen Biotherapeutics Related Developments
11.10 Takeda Pharmaceutical Co Ltd
11.10.1 Takeda Pharmaceutical Co Ltd Corporation Information
11.10.2 Takeda Pharmaceutical Co Ltd Description and Business Overview
11.10.3 Takeda Pharmaceutical Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Products Offered
11.10.5 Takeda Pharmaceutical Co Ltd Related Developments
11.1 Aduro BioTech Inc
11.1.1 Aduro BioTech Inc Corporation Information
11.1.2 Aduro BioTech Inc Description and Business Overview
11.1.3 Aduro BioTech Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Products Offered
11.1.5 Aduro BioTech Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Granulocyte Macrophage Colony Stimulating Factor Market Estimates and Projections by Region
12.1.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Regions 2021-2026
12.1.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast by Regions 2021-2026
12.2 North America Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast (2021-2026)
12.2.1 North America: Granulocyte Macrophage Colony Stimulating Factor Sales Forecast (2021-2026)
12.2.2 North America: Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast (2021-2026)
12.2.3 North America: Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Country (2021-2026)
12.3 Europe Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast (2021-2026)
12.3.1 Europe: Granulocyte Macrophage Colony Stimulating Factor Sales Forecast (2021-2026)
12.3.2 Europe: Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast (2021-2026)
12.3.3 Europe: Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Granulocyte Macrophage Colony Stimulating Factor Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Region (2021-2026)
12.5 Latin America Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast (2021-2026)
12.5.1 Latin America: Granulocyte Macrophage Colony Stimulating Factor Sales Forecast (2021-2026)
12.5.2 Latin America: Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast (2021-2026)
12.5.3 Latin America: Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Granulocyte Macrophage Colony Stimulating Factor Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Granulocyte Macrophage Colony Stimulating Factor Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Granulocyte Macrophage Colony Stimulating Factor Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Granulocyte Macrophage Colony Stimulating Factor Market Segments
Table 2. Ranking of Global Top Granulocyte Macrophage Colony Stimulating Factor Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Granulocyte Macrophage Colony Stimulating Factor Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of CG-0070
Table 5. Major Manufacturers of Gimsilumab
Table 6. Major Manufacturers of GSK-3196165
Table 7. Major Manufacturers of Lenzilumab
Table 8. Major Manufacturers of MGN-1601
Table 9. Major Manufacturers of Others
Table 10. Global Granulocyte Macrophage Colony Stimulating Factor Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global Granulocyte Macrophage Colony Stimulating Factor Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Regions 2015-2020 (K Pcs)
Table 13. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Regions (2015-2020)
Table 14. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global Granulocyte Macrophage Colony Stimulating Factor Sales Share by Manufacturers (2015-2020)
Table 17. Global Granulocyte Macrophage Colony Stimulating Factor Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Granulocyte Macrophage Colony Stimulating Factor by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Granulocyte Macrophage Colony Stimulating Factor as of 2019)
Table 19. Granulocyte Macrophage Colony Stimulating Factor Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Granulocyte Macrophage Colony Stimulating Factor Price (2015-2020) (USD/Pcs)
Table 22. Granulocyte Macrophage Colony Stimulating Factor Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Granulocyte Macrophage Colony Stimulating Factor Product Type
Table 24. Date of International Manufacturers Enter into Granulocyte Macrophage Colony Stimulating Factor Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2015-2020) (K Pcs)
Table 27. Global Granulocyte Macrophage Colony Stimulating Factor Sales Share by Type (2015-2020)
Table 28. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Type (2015-2020)
Table 30. Granulocyte Macrophage Colony Stimulating Factor Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2015-2020) (K Pcs)
Table 32. Global Granulocyte Macrophage Colony Stimulating Factor Sales Share by Application (2015-2020)
Table 33. North America Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2015-2020) (K Pcs)
Table 34. North America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country (2015-2020)
Table 35. North America Granulocyte Macrophage Colony Stimulating Factor Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Country (2015-2020)
Table 37. North America Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2015-2020) (K Pcs)
Table 38. North America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2015-2020)
Table 39. North America Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2015-2020) (K Pcs)
Table 40. North America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2015-2020)
Table 41. Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2015-2020) (K Pcs)
Table 42. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country (2015-2020)
Table 43. Europe Granulocyte Macrophage Colony Stimulating Factor Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Country (2015-2020)
Table 45. Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2015-2020) (K Pcs)
Table 46. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2015-2020)
Table 47. Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2015-2020) (K Pcs)
Table 48. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales by Region (2015-2020) (K Pcs)
Table 50. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2015-2020) (K Pcs)
Table 54. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2015-2020) (K Pcs)
Table 56. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2015-2020)
Table 57. Latin America Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2015-2020) (K Pcs)
Table 58. Latin America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Granulocyte Macrophage Colony Stimulating Factor Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Country (2015-2020)
Table 61. Latin America Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2015-2020) (K Pcs)
Table 62. Latin America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2015-2020)
Table 63. Latin America Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2015-2020) (K Pcs)
Table 64. Latin America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2015-2020) (K Pcs)
Table 66. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2015-2020) (K Pcs)
Table 70. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2015-2020) (K Pcs)
Table 72. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2015-2020)
Table 73. Aduro BioTech Inc Corporation Information
Table 74. Aduro BioTech Inc Description and Major Businesses
Table 75. Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. Aduro BioTech Inc Product
Table 77. Aduro BioTech Inc Recent Development
Table 78. Amgen Inc Corporation Information
Table 79. Amgen Inc Description and Major Businesses
Table 80. Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. Amgen Inc Product
Table 82. Amgen Inc Recent Development
Table 83. BriaCell Therapeutics Corp Corporation Information
Table 84. BriaCell Therapeutics Corp Description and Major Businesses
Table 85. BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. BriaCell Therapeutics Corp Product
Table 87. BriaCell Therapeutics Corp Recent Development
Table 88. Cold Genesys Inc Corporation Information
Table 89. Cold Genesys Inc Description and Major Businesses
Table 90. Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Cold Genesys Inc Product
Table 92. Cold Genesys Inc Recent Development
Table 93. GlaxoSmithKline Plc Corporation Information
Table 94. GlaxoSmithKline Plc Description and Major Businesses
Table 95. GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. GlaxoSmithKline Plc Product
Table 97. GlaxoSmithKline Plc Recent Development
Table 98. Humanigen Inc Corporation Information
Table 99. Humanigen Inc Description and Major Businesses
Table 100. Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. Humanigen Inc Product
Table 102. Humanigen Inc Recent Development
Table 103. Mologen AG Corporation Information
Table 104. Mologen AG Description and Major Businesses
Table 105. Mologen AG Granulocyte Macrophage Colony Stimulating Factor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 106. Mologen AG Product
Table 107. Mologen AG Recent Development
Table 108. Morphotek Inc Corporation Information
Table 109. Morphotek Inc Description and Major Businesses
Table 110. Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 111. Morphotek Inc Product
Table 112. Morphotek Inc Recent Development
Table 113. Sillajen Biotherapeutics Corporation Information
Table 114. Sillajen Biotherapeutics Description and Major Businesses
Table 115. Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 116. Sillajen Biotherapeutics Product
Table 117. Sillajen Biotherapeutics Recent Development
Table 118. Takeda Pharmaceutical Co Ltd Corporation Information
Table 119. Takeda Pharmaceutical Co Ltd Description and Major Businesses
Table 120. Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 121. Takeda Pharmaceutical Co Ltd Product
Table 122. Takeda Pharmaceutical Co Ltd Recent Development
Table 123. Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Regions (2021-2026) (K Pcs)
Table 124. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share Forecast by Regions (2021-2026)
Table 125. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 126. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share Forecast by Regions (2021-2026)
Table 127. North America: Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Country (2021-2026) (K Pcs)
Table 128. North America: Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Europe: Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Country (2021-2026) (K Pcs)
Table 130. Europe: Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Asia Pacific: Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Region (2021-2026) (K Pcs)
Table 132. Asia Pacific: Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast by Region (2021-2026) (US$ Million)
Table 133. Latin America: Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Country (2021-2026) (K Pcs)
Table 134. Latin America: Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Middle East and Africa: Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Country (2021-2026) (K Pcs)
Table 136. Middle East and Africa: Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 138. Key Challenges
Table 139. Market Risks
Table 140. Main Points Interviewed from Key Granulocyte Macrophage Colony Stimulating Factor Players
Table 141. Granulocyte Macrophage Colony Stimulating Factor Customers List
Table 142. Granulocyte Macrophage Colony Stimulating Factor Distributors List
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Granulocyte Macrophage Colony Stimulating Factor Product Picture
Figure 2. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type in 2020 & 2026
Figure 3. CG-0070 Product Picture
Figure 4. Gimsilumab Product Picture
Figure 5. GSK-3196165 Product Picture
Figure 6. Lenzilumab Product Picture
Figure 7. MGN-1601 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application in 2020 & 2026
Figure 10. Solid Tumor
Figure 11. Lymphoma
Figure 12. Kidney Cancer
Figure 13. Lung Disease
Figure 14. Others
Figure 15. Granulocyte Macrophage Colony Stimulating Factor Report Years Considered
Figure 16. Global Granulocyte Macrophage Colony Stimulating Factor Market Size 2015-2026 (US$ Million)
Figure 17. Global Granulocyte Macrophage Colony Stimulating Factor Sales 2015-2026 (K Pcs)
Figure 18. Global Granulocyte Macrophage Colony Stimulating Factor Market Size Market Share by Region: 2020 Versus 2026
Figure 19. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Region (2015-2020)
Figure 20. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Region in 2019
Figure 21. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Region (2015-2020)
Figure 22. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Region in 2019
Figure 23. Global Granulocyte Macrophage Colony Stimulating Factor Sales Share by Manufacturer in 2019
Figure 24. The Top 10 and 5 Players Market Share by Granulocyte Macrophage Colony Stimulating Factor Revenue in 2019
Figure 25. Granulocyte Macrophage Colony Stimulating Factor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 26. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2015-2020)
Figure 27. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type in 2019
Figure 28. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Type (2015-2020)
Figure 29. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Type in 2019
Figure 30. Global Granulocyte Macrophage Colony Stimulating Factor Market Share by Price Range (2015-2020)
Figure 31. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2015-2020)
Figure 32. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application in 2019
Figure 33. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Application (2015-2020)
Figure 34. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Application in 2019
Figure 35. North America Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate 2015-2020 (K Pcs)
Figure 36. North America Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 37. North America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country in 2019
Figure 38. North America Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Country in 2019
Figure 39. U.S. Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. U.S. Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Canada Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 42. Canada Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. North America Granulocyte Macrophage Colony Stimulating Factor Market Share by Type in 2019
Figure 44. North America Granulocyte Macrophage Colony Stimulating Factor Market Share by Application in 2019
Figure 45. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate 2015-2020 (K Pcs)
Figure 46. Europe Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country in 2019
Figure 48. Europe Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Country in 2019
Figure 49. Germany Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. Germany Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. France Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. U.K. Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Italy Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 58. Russia Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Europe Granulocyte Macrophage Colony Stimulating Factor Market Share by Type in 2019
Figure 60. Europe Granulocyte Macrophage Colony Stimulating Factor Market Share by Application in 2019
Figure 61. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate 2015-2020 (K Pcs)
Figure 62. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 63. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Region in 2019
Figure 64. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Region in 2019
Figure 65. China Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. China Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Japan Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. Japan Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. South Korea Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. South Korea Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. India Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. India Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Australia Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Australia Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Taiwan Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Taiwan Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Indonesia Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Indonesia Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Thailand Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Thailand Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Malaysia Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Malaysia Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Philippines Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Philippines Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Vietnam Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 86. Vietnam Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Market Share by Type in 2019
Figure 88. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Market Share by Application in 2019
Figure 89. Latin America Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate 2015-2020 (K Pcs)
Figure 90. Latin America Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 91. Latin America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country in 2019
Figure 92. Latin America Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Country in 2019
Figure 93. Mexico Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Mexico Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Brazil Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Brazil Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Argentina Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 98. Argentina Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 99. Latin America Granulocyte Macrophage Colony Stimulating Factor Market Share by Type in 2019
Figure 100. Latin America Granulocyte Macrophage Colony Stimulating Factor Market Share by Application in 2019
Figure 101. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate 2015-2020 (K Pcs)
Figure 102. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 103. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country in 2019
Figure 104. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Country in 2019
Figure 105. Turkey Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Turkey Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Saudi Arabia Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. Saudi Arabia Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. U.A.E Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 110. U.A.E Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 111. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Market Share by Type in 2019
Figure 112. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Market Share by Application in 2019
Figure 113. North America Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. North America Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Europe Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Latin America Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Latin America Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 122. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Porter's Five Forces Analysis
Figure 124. Channels of Distribution
Figure 125. Distributors Profiles
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed
卵胞刺激ホルモン（FSH）の世界市場（～2026年） Market Analysis and Insights: Global Follicle-stimulating Hormone (FSH) Market The global Follicle-stimulating Hormone (FSH) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Follicle-stimulating Hormone (FSH) Scope and …- メラノサイト刺激ホルモン受容体の世界市場（～2026年） Market Analysis and Insights: Global Melanocyte Stimulating Hormone Receptor Market The global Melanocyte Stimulating Hormone Receptor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Melanocyte Stimulating Hormone Rece…
- モノクローナル抗体(mAb)バイオシミラーの世界市場（～2026年） A biosimilar medicine is a medicinal product of biological origin that is produced in a living organism following a procedure equivalent to a biological drug and adhering to the same quality criteria, hence the name biosimilars. In short, they are biological drugs that are “equivalent” in terms of q…
- がん支持療法の世界市場（～2026年） The cancer supportive care product market consists of drugs intended to prevent or treat the symptoms of cancer, and reduce the side effects of cancer treatments. Instead of extending a patient’s life expectancy, the emphasis is on improving overall quality of life. With growing prevalence of cancer…
- 第IX因子欠乏症治療の世界市場（～2026年） Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1. Deficiency of this protein causes hemophilia B. In this market study, analysts have estimated the prophylaxis segment to dominate the factor IX deficiency treatment market dur…